1. ID09, A Newly-Designed Tubulin Inhibitor, Regulating the Proliferation, Migration, EMT Process and Apoptosis of Oral Squamous Cell Carcinoma
- Author
-
Feng, Qiushi, Yang, Panpan, Wang, He, Li, Congshan, Hasegawa, Tomoka, Liu, Zhaopeng, and Li, Minqi
- Subjects
Male ,Epithelial-Mesenchymal Transition ,MAP Kinase Signaling System ,Malignant Biological Behaviors ,Tubulin Inhibitor ID09 ,Mice, Nude ,Apoptosis ,Ras-Erk Pathway ,Oral Squamous Cell Carcinoma ,Applied Microbiology and Biotechnology ,Mice ,Cell Movement ,Cell Line, Tumor ,Animals ,Humans ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Cell Proliferation ,Mice, Inbred BALB C ,Mcl-1 ,Cell Cycle Checkpoints ,Cell Biology ,Xenograft Model Antitumor Assays ,Tubulin Modulators ,Carcinoma, Squamous Cell ,Myeloid Cell Leukemia Sequence 1 Protein ,Mouth Neoplasms ,Research Paper ,Developmental Biology - Abstract
Microtubules, a major target in oral squamous cell carcinoma (OSCC) chemotherapy, contribute to multiple malignant biological behaviors, including proliferation, migration, and epithelial-mesenchymal transition (EMT). Surpassing traditional tubulin inhibitors, ID09 emerges with brilliant solubility, photostability, and drug-sensitivity in multidrug-resistant cells. Its anti-tumor effects have been briefly verified in lung adenocarcinoma and hepatocellular carcinoma. However, whether OSCC is sensitive to ID09 and the potential mechanisms remain ambiguous, which are research purposes this study aimed to achieve. Various approaches were applied, including clone formation assay, flow cytometry, wound healing assay, Transwell assay, cell counting kit-8 assay, Western blot, qRT-PCR, and in vivo experiment. The experimental results revealed that ID09 not only contributed to cell cycle arrest, reduced migration, and reversed EMT, but accelerated mitochondria-initiated apoptosis. Remarkably, Western blot detected diminishment in expression of Mcl-1 due to the deactivation of Ras-Erk pathway, resulting in ID09-induced apoptosis, proliferation and migration suppression, which could be offset by Erk1/2 phosphorylation agonist Ro 67-7476. This study initially explored the essential role Mcl-1 played and the regulatory effect of Ras-Erk pathway in anti-cancer process triggered by tubulin inhibitor, broadening clinical horizon of tubulin inhibitors in oral squamous cell carcinoma chemotherapy application.
- Published
- 2022
- Full Text
- View/download PDF